FDA Person
FDAAmir Alavi
View detailed information about Amir Alavi, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 18 inspections of 17 companies, 2017–2024.
Inspections (18)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| December 13, 2024 | Baxter Healthcare (Guangzhou) Co., Ltd. | Not classified | #1256906 | |
| December 3, 2024 | Baxter Healthcare (Shanghai) Co. Ltd. | Not classified | #1256907 | |
| December 3, 2024 | GE Healthcare (Shanghai) Co., Ltd. | VAI | Drug Quality Assurance | #1256907 |
| September 6, 2024 | Rechon Life Science AB | OAI | Drug Quality Assurance | #1251480 |
| July 19, 2024 | Baxter Healthcare Corporation | VAI | Drug Quality Assurance | #1240745 |
| April 2, 2024 | Nang Kuang Pharmaceutical Co., Ltd. | OAI | Drug Quality Assurance | #1236762 |
| December 15, 2023 | B. Braun Medical Inc | VAI | Drug Quality Assurance | #1226163 |
| July 28, 2023 | Organo Sintesis, S.A. De C.V. | VAI | Drug Quality Assurance | #1218259 |
| February 13, 2023 | K.C. Pharmaceuticals, Inc | OAI | Drug Quality Assurance | #1197242 |
| September 27, 2019 | Latina Pharma S.p.A. | VAI | Drug Quality Assurance | #1109198 |
| April 24, 2019 | ten23 health Valais AG | Not classified | #1092020 | |
| April 12, 2019 | Redox S.r.l. | Not classified | #1090329 | |
| January 18, 2019 | Teva Parenteral Medicines, Inc. | VAI | Generic Drug Evaluation | #1077528 |
| September 25, 2018 | EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA | VAI | Drug Quality Assurance | #1068723 |
| August 22, 2018 | Lonza Manufacturing LLC | VAI | Drug Quality Assurance | #1063110 |
| June 7, 2018 | Bright Innovation Labs | OAI | Drug Quality Assurance | #1054722 |
| April 21, 2017 | Latina Pharma S.p.A. | VAI | Drug Quality Assurance | #1018753 |
| March 31, 2017 | Amphastar Pharmaceuticals, Inc. | OAI | Compliance: Devices | #1009137 |
Documents (17)
- EIR · Pyramid Laboratories, Inc. · September 29, 2021
- 483 · TOLMAR, Inc. · June 17, 2022
- 483 · K.C. Pharmaceuticals, Inc. · February 13, 2023
- 483 · Baxter Healthcare (Guangzhou) Co., Ltd. · December 13, 2024
- 483 · Organo Sintesis, S.A. De C.V. · July 28, 2023
- 483 · Nang Kuang Pharmaceutical Co., Ltd. · April 2, 2024
- 483 · Latina Pharma S.p.A.
- 483 · Organo Sintesis, S.A. De C.V.
- 483 · Teva Parenteral Medicines, Inc. · January 18, 2019
- 483 · Ajinomoto Althea, Inc. · May 25, 2021
- 483 · Baxter Healthcare Corporation · July 19, 2024
- 483 · ten23 health Valais AG · April 24, 2019
- 483 · Rechon Life Science AB · September 6, 2024
- 483 · Genentech Inc · August 13, 2018
- 483 · Pyramid Laboratories, Inc. · September 29, 2021
- 483 · B. Braun Medical Inc · December 15, 2023
- 483 · K.C. Pharmaceuticals, Inc · February 13, 2023
Frequently inspected with (10)
Amanda L. Fyles
investigator
3 shared
Walden H. Lee
Chemist/Investigator - Pharmaceutical Quality
3 shared
Carrie A. Hughes
2 shared
Dipesh K. Shah
2 shared
Jamie L. Dion
2 shared
Saleem A. Akhtar
2 shared
Adam R. Cooke
Commissioned Corps of the U.S. Public Health Service
1 shared
Cecilia H. Kieu
1 shared
Christopher R. Czajka
Consumer Safety Officer (Inspector)
1 shared
Claudia M. Perez-Kasmarski
1 shared
Person Information
Name
Amir Alavi
Title
investigator
Role
COMPANY REP
ID: d7179128-eb3f-489e-97cf-e2c5e5539a00
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.